Shin Poong Pharm.Co.Ltd. (019170) — Financial Flexibility Index
Shin Poong Pharm.Co.Ltd. (019170) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of ₩4.11 Billion (operating CF ₩3.42 Billion minus capex ₩694.80 Million) represents 0% of total liabilities (₩81.74 Billion). Check Shin Poong Pharm.Co.Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shin Poong Pharm.Co.Ltd. Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Shin Poong Pharm.Co.Ltd. across 22 annual periods. For the full cash flow conversion analysis, see Shin Poong Pharm.Co.Ltd. operating cash flow efficiency.
Annual Financial Flexibility Index for Shin Poong Pharm.Co.Ltd. (2004–2025)
Year-by-year free cash flow to debt coverage for Shin Poong Pharm.Co.Ltd.. Explore Shin Poong Pharm.Co.Ltd. (019170) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | ₩21.24 Billion | ₩17.25 Billion | ₩81.74 Billion | ▲ +340.8% |
| 2024 | -0.11x | ₩-9.07 Billion | ₩-15.15 Billion | ₩84.00 Billion | ▲ +12.5% |
| 2023 | -0.12x | ₩-9.78 Billion | ₩-24.81 Billion | ₩79.30 Billion | ▲ +81.2% |
| 2022 | -0.66x | ₩-20.21 Billion | ₩-26.44 Billion | ₩30.78 Billion | ▲ +62.5% |
| 2021 | -1.75x | ₩-66.60 Billion | ₩-71.03 Billion | ₩38.03 Billion | ▼ -969.9% |
| 2020 | 0.20x | ₩22.72 Billion | ₩20.06 Billion | ₩112.82 Billion | ▲ +9.6% |
| 2019 | 0.18x | ₩31.42 Billion | ₩19.35 Billion | ₩170.99 Billion | ▼ -5.8% |
| 2018 | 0.20x | ₩33.85 Billion | ₩32.05 Billion | ₩173.47 Billion | ▲ +158.8% |
| 2017 | 0.08x | ₩13.23 Billion | ₩10.15 Billion | ₩175.50 Billion | ▼ -26.5% |
| 2016 | 0.10x | ₩20.46 Billion | ₩18.96 Billion | ₩199.64 Billion | ▲ +87.7% |
| 2015 | 0.05x | ₩11.79 Billion | ₩9.89 Billion | ₩215.87 Billion | ▲ +62.3% |
| 2014 | 0.03x | ₩7.33 Billion | ₩-48.16 Million | ₩217.78 Billion | ▼ -66.5% |
| 2013 | 0.10x | ₩20.85 Billion | ₩11.45 Billion | ₩207.57 Billion | ▼ -61.5% |
| 2012 | 0.26x | ₩49.86 Billion | ₩30.79 Billion | ₩190.95 Billion | ▲ +6.5% |
| 2011 | 0.25x | ₩48.70 Billion | ₩28.73 Billion | ₩198.64 Billion | ▲ +61.5% |
| 2010 | 0.15x | ₩25.89 Billion | ₩11.36 Billion | ₩170.54 Billion | ▼ -37.6% |
| 2009 | 0.24x | ₩40.10 Billion | ₩9.82 Billion | ₩164.84 Billion | ▼ -49.0% |
| 2008 | 0.48x | ₩67.15 Billion | ₩23.57 Billion | ₩140.67 Billion | ▲ +60.3% |
| 2007 | 0.30x | ₩30.78 Billion | ₩9.77 Billion | ₩103.35 Billion | ▲ +47.7% |
| 2006 | 0.20x | ₩19.11 Billion | ₩10.71 Billion | ₩94.79 Billion | ▲ +45.7% |
| 2005 | 0.14x | ₩12.79 Billion | ₩4.93 Billion | ₩92.42 Billion | ▼ -34.0% |
| 2004 | 0.21x | ₩18.32 Billion | ₩10.49 Billion | ₩87.42 Billion | — |